This is a phase 3, multicenter, randomized, placebo-controlled, double- blinded clinical trial investigating the efficacy and safety of maximum tolerated dose (MTD) of tirzepatide (10 mg or 15 mg) administered once weekly (QW) subcutaneously compared with placebo for body weight management, in participants who have obesity, or overweight with at least 1 obesity-related complication (excluding type 2 diabetes), and with at least 5% weight reduction following a 12-week intensive lifestyle intervention lead-in
In combination with diet and exercise, Ozempic can help to improve glycaemic control
The compound belongs to a class of heterocyclic quinolinium derivatives investigated for their interaction with biochemical regulatory enzymes and metabolic signalling systems
World Medical Association
Maeda, S., Yanagihara, T., Inflammatory cytokines (Il-4, IL-5 and IL-13), Nippon Rinsho, 59:1894-1899 (2001)
Ships free, sealed, and temperature-monitored, with continuing access to your care team